Skip to content

Compassion Training and Pain

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01776645
Enrollment
56
Registered
2013-01-28
Start date
2013-01-31
Completion date
2013-05-31
Last updated
2013-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain

Brief summary

The purpose of this study is to determine whether compassion training will improve the physical and psychological well-being of patients with chronic pain. The investigators also want to determine whether any benefit of compassion training in the patients spreads to significant others with whom the patient has a close relationship.

Interventions

BEHAVIORALCompassion Cultivation Training Course

Sponsors

Stanford University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Age 18+ and chronic pain for \>6months 2. Pain over the last month 3. Ability to read, write, and converse in English 4. If being treated for pain condition, then stable treatment regimen. For significant others: 1)18 years of age or older 2)Ability to read, write, and converse in English

Exclusion criteria

For patients and significant others: 1)Current or history of a psychological disorder that would interfere with study procedures, at the discretion of the researcher. For patients only: 1. prior compassion meditation experience 2. on going legal action or disability claim 3. currently pregnant or planning to become pregnant

Design outcomes

Primary

MeasureTime frameDescription
Change in Brief Pain InventoryBaseline and end of 9-week treatment protocolIntensity - pain severity as measured by a 0 to 10 visual analogue scale. 0 = no pain, 10 = worst pain imaginable
Change in Chronic Pain Acceptance QuestionnaireBaseline and end of 9-week treatment protocol

Secondary

MeasureTime frameDescription
Change in Brief Pain InventoryBaseline to end of 9-week treatment protocolInterference score - Interference as measured by a 0 to 10 numerical rating scale. 0 = does not interfere, 10 = completely interferes

Other

MeasureTime frameDescription
Change in Emotional DistressBaseline and end of 9-week treatment protocolAs assessed by the Hospital Anxiety and Depression Scale
Qualitative MeasuresBaseline and end of 9-week treatment protocolQualitative analysis of interviews
Change in Overall Health and Well-beingBaseline and end of 9-week treatment protocolAs assessed by Ryff's psychological well-being scales
Change in CompassionBaseline and end of 9-week treatment protocolAs assessed by Neff's Self-Compassion Scale

Countries

United States

Participant flow

Participants by arm

ArmCount
Compassion Cultivation Training - Participants With Chronic Pa
Compassion Cultivation Training Course - Participants with Chronic Pain
28
Significant Others Group
Significant Others of Participants with Chronic Pain
28
Total56

Baseline characteristics

CharacteristicSignificant Others GroupCompassion Cultivation Training - Participants With Chronic PaTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
4 Participants2 Participants6 Participants
Age, Categorical
Between 18 and 65 years
24 Participants26 Participants50 Participants
Age Continuous50.71 years
STANDARD_DEVIATION 12.59
49.61 years
STANDARD_DEVIATION 10.59
50.16 years
STANDARD_DEVIATION 11.75
Region of Enrollment
United States
28 participants28 participants56 participants
Sex: Female, Male
Female
7 Participants24 Participants31 Participants
Sex: Female, Male
Male
21 Participants4 Participants25 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 280 / 28
serious
Total, serious adverse events
0 / 280 / 28

Outcome results

Primary

Change in Brief Pain Inventory

Intensity - pain severity as measured by a 0 to 10 visual analogue scale. 0 = no pain, 10 = worst pain imaginable

Time frame: Baseline and end of 9-week treatment protocol

Population: 2 participants excluded from analysis: 1 did not complete the final questionnaire battery, 1 reported no pain at baseline and thus could not be included as a patient with chronic pain

ArmMeasureValue (MEAN)Dispersion
Compassion Cultivation TrainingChange in Brief Pain Inventory-1.46 units on a scaleStandard Deviation 1.29
Primary

Change in Chronic Pain Acceptance Questionnaire

Time frame: Baseline and end of 9-week treatment protocol

Secondary

Change in Brief Pain Inventory

Interference score - Interference as measured by a 0 to 10 numerical rating scale. 0 = does not interfere, 10 = completely interferes

Time frame: Baseline to end of 9-week treatment protocol

Population: 2 participants excluded from analysis: 1 did not complete the final questionnaire battery, 1 reported no pain at baseline and thus could not be included as a patient with chronic pain

ArmMeasureValue (MEAN)Dispersion
Compassion Cultivation TrainingChange in Brief Pain Inventory-1.18 units on a scaleStandard Deviation 1.94
Other Pre-specified

Change in Compassion

As assessed by Neff's Self-Compassion Scale

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Change in Compassion

As assessed by Pommier's Compassion for Other's Scale

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Change in Compassion

As assessed by Compassionate Love Scale adapted for close other

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Change in Emotional Distress

As assessed by the Hospital Anxiety and Depression Scale

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Change in Emotional Distress

As Assessed by the PROMIS Anger Scale

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Change in Emotional Distress

As assessed by the PROMIS Social Isolation Scale

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Change in Overall Health and Well-being

As assessed by PROMIS Global Health Scale

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Change in Overall Health and Well-being

As assessed by Ryff's psychological well-being scales

Time frame: Baseline and end of 9-week treatment protocol

Other Pre-specified

Qualitative Measures

Qualitative analysis of interviews

Time frame: Baseline and end of 9-week treatment protocol

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026